Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

(NASDAQ:FMST),(CNSX:FAT.CN),(NASDAQ:FMSTW),(Frankfurt:F0R),(Frankfurt:F0R.F), VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce its plans for a $9 million exploration program in 2026 (the “2026 Exploration Program“), primarily focused on advancing its Athabasca Basin uranium projects. The Company maintains a portfolio of […]

Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy

BOSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced the successful dosing of the first patient in the United States in the TENACITY-01 clinical trial (NCT07070219). The TENACITY-01 trial is evaluating CTD402, Imviva's investigational allogeneic anti-CD7 CAR-T cell therapy, for the treatment of

FLINT Secures $451 million in New Contract Awards and Renewals

(TSX:FLNT), CALGARY, Alberta, Dec. 22, 2025 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company“) (TSX: FLNT) is pleased to announce that since the release of its third quarter results and the press release of October 28, 2025 announcing new contract awards and renewals that were estimated to generate approximately $320 million in backlog, FLINT

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NASDAQ:CVRX), MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14,

Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NYSE:IR), DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial officer, and Scott Watson, senior vice president and general manager, Life Science Technologies, will present

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

PISCATAWAY, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — The DALI Alliance, recognized as the international authority in lighting technology standardization, proudly announces the launch of its new test and certification specifications for Wireless to DALI Gateways. This groundbreaking release allows seamless control of wired DALI devices from either Bluetooth(R) NLC (Networked Lighting Control) or Zigbee

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

(NASDAQ:ENTX), JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and pharmacodynamic data that supports further development of a proprietary long-acting parathyroid hormone (PTH) analog using its N-Tab(R) platform

Aether Holdings Advances Growth Strategy with Purchase of Manhattan Office

Aether Holdings Advances Growth Strategy with Purchase of Manhattan Office GlobeNewswire December 22, 2025 NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) — Aether Holdings, Inc. (Nasdaq: ATHR) (“Aether” or the “Company”), an emerging financial technology holding company developing data-driven platforms and media assets for investors, today announced the purchase of a new corporate headquarters office

Vivos Inc Summarzes Preogress in its Animal Therapy Division

Vivos Inc Summarzes Preogress in its Animal Therapy Division GlobeNewswire December 22, 2025 Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) The IsoPet division reported an 800% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise

Vivakor Signs Letter of Intent to Acquire Coyote Oilfield Services, Expanding Integrated Midstream Capabilities

Vivakor Signs Letter of Intent to Acquire Coyote Oilfield Services, Expanding Integrated Midstream Capabilities GlobeNewswire December 22, 2025 Dallas, TX, Dec. 22, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation service, announced today that it has signed a non-binding letter of

Scroll to Top